Lire
Dec. 16, 2020 | Today s news and insights for biopharma leaders BROUGHT TO YOU BY ZS How AI Is Enabling Better Patient InsightsA look at how UCB is utilizing AI-enabled dynamic targeting to collect better insights and get solutions into the hands of the patients who need them. Read now. Pharmacquired: What a surprise deal does for AstraZeneca and Alexion
The $39 billion tie-up between the two companies sparked questions about whether Alexion could have sold for more. Yet, it doesn t look like rival bidders stood in AstraZeneca s way. With trial plans, Novo wagers its diabetes drug can help treat Alzheimer s
Similar diabetes drugs from Novo have shown signs of promise in treating dementia. The Danish biotech is now putting that hypothesis to the test.